Table 1.

Patient diagnosis and oncology outcome

Case	Age	Gender	Follow-up	Diagnosis	Staging	Blood loss	Operation time	Margin	Local recurrence	Site of metastasis	Oncologic results
1	41	M	3	adenocarcinoma	III A	2300	220	W	N	liver	CDF
2	23	F	7	GCT	II B	1200	180	W	N	N	CDF
3	75	F	10	sarcoma	II B	1300	150	M	N	N	CDF
4	39	M	12	plasmacytoma	II B	1000	190	W	N	N	CDF
5	59	M	16	chondrosarcoma	II B	1800	100	W	Y	N	NED
6	43	F	18	chondrosarcoma	II B	800	290	W	Y	N	NED
7	20	F	19	sarcoma	II B	700	120	W	N	lung	DOD
8	46	M	30	transitional cell carcinoma	III A	1800	200	M	Y	kidney	DOD
9	73	F	30	MFH	II B	1500	180	M	N	lung	DOD
10	66	F	36	chondrosarcoma	II B	800	120	W	N	N	CDF
11	17	M	45	sarcoma	II B	1600	200	W	N	lung	DOD
12	40	F	56	GCT	II B	1400	210	W	N	N	NED
13	47	F	56	angiosarcoma	II B	1900	205	I	N	N	CDF
14	12	F	67	GCT	II B	800	175	W	N	N	NEN
15	36	M	75	synovisarcoma	II B	900	160	M	Y	N	NED
16	33	F	80	chondrosarcoma	II B	1600	220	W	N	N	NED